NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index.
The underlying index was composed of common stocks ofU. S. biotechnology and genome companies.
These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 6.04% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 5.40% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 5.24% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 5.23% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 5.22% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 5.16% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.99% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.98% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 4.90% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 4.89% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 4.78% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 4.58% |
| FOLD | Amicus Therapeutics Inc | Healthcare | Biotechnology | 4.16% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.73% |
| BCRX | BioCryst Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.66% |
| DVAX | Dynavax Technologies Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.58% |
| PTGX | Protagonist Therapeutics Inc | Healthcare | Biotechnology | 3.38% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 3.32% |
| AVXL | Anavex Life Sciences Corp | Healthcare | Biotechnology | 3.21% |
| TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 3.11% |